Generative AI-driven de novo design of high-affinity, epitope-specific antibodies targeting the CD93-IGFBP7 axis for cancer immunotherapy.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Generative AI contributed a candidate antibody that showed measured target binding/blockade and tumor-model activity; the evidence is preclinical and does not establish human efficacy.
Technology: A generative AI model designed candidates for a target interface; the lead was selected and tested experimentally. No sequence or operational design details reproduced.
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- A generative AI model designed candidates for a target interface; the lead was selected and tested experimentally. No sequence or operational design details reproduced.
- Limitation / still unknown
- Biophysical binding, cell-based blocking and tumor-model experiments tested the candidate. This is preclinical evidence, not human or clinical validation.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://academic.oup.com/abt/article/9/3/323/8664001 · https://europepmc.org/article/MED/42592032
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.